Point-of-Care Diagnostics Market to Reach USD 85.2 Billion by 2035 with 6.8% CAGR Driven by Rapid Testing Innovation

The Point-of-Care (POC) Diagnostics Market is entering an era of transformation as demand for fast, accurate, and accessible testing continues to grow worldwide. Valued at USD 44.1 billion in 2025, the market is projected to nearly double and reach USD 85.2 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.8%.

The shift toward decentralized healthcare, coupled with the rising global prevalence of infectious and chronic diseases, has significantly accelerated the adoption of point-of-care diagnostics. From glucose and HbA1c monitoring to rapid COVID-19 and influenza testing, these devices are enabling physicians, pharmacists, and patients themselves to detect conditions earlier, treat faster, and reduce dependence on centralized laboratories.

Market Dynamics Driving Growth

The surge in demand for point-of-care diagnostics stems from several key factors. Growing emphasis on preventive healthcare has led governments and healthcare providers to prioritize rapid detection technologies. Public awareness campaigns-particularly during the COVID-19 pandemic-created long-term behavioral shifts, with patients and clinicians embracing near-patient testing as part of routine care.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-gb-17291

Advances in assay design, microfluidics, and digital integration have made POC devices more accurate and user-friendly, while wireless connectivity and mobile applications allow test results to be instantly shared with healthcare professionals. This fusion of biotechnology and digital health is redefining diagnostics, improving both outcomes and patient experiences.

Hospitals remain the largest end-user group, performing more than 27% of POC tests globally in 2025, but growth in home-based and pharmacy-driven testing is creating opportunities for expansion.

Segmental Analysis Highlights

By product type, dipsticks stand out as the leading segment, projected to hold 41.7% of total market share in 2025. Their affordability, simplicity, and quick results make them essential for mass screenings and routine diagnostics across both advanced and developing healthcare systems.

By sample type, saliva-based testing is revolutionizing diagnostics, with an expected 36.9% market share by 2025. Its non-invasive collection method, lower infection risk, and suitability for both infectious and chronic disease monitoring have driven widespread acceptance.

When analyzed by test type, COVID-19 diagnostics dominate with 38.4% of global share in 2025. The pandemic not only accelerated innovation in rapid testing kits but also established a permanent role for POC tests in disease surveillance and preparedness strategies.

Among devices, handheld POC monitoring systems command 41.3% share of the market. Their portability and ability to track conditions such as diabetes, hypertension, and respiratory disorders make them highly sought after by both clinicians and patients.

Global Market Outlook

Between 2012 and 2025, sales of point-of-care diagnostics expanded at a CAGR of 6.2%, contributing to 40% of the global in-vitro diagnostics industry. Looking ahead, sustained growth is anticipated as both developed and emerging markets intensify adoption.

The United States continues to dominate the global landscape, holding a large revenue share and maintaining steady growth with a CAGR of 6.8% through 2035. Strong regulatory frameworks, awareness campaigns, and industry-backed educational programs-such as the American Association for Clinical Chemistry's Point-of-Care Boot Camp-are accelerating adoption.

Germany represents a key hub in Europe, with a 25.2% share of the regional market in 2025. Primary care physicians widely use POC diagnostics as first-line tools, setting a precedent for neighboring nations to follow.

China is emerging as a standout growth market, projected to grow at a remarkable 9.0% CAGR through 2035. Investments in healthcare infrastructure, rising awareness among both patients and clinicians, and broader access to advanced diagnostic tools are fueling its expansion.

Opportunities and Challenges

Opportunities for manufacturers are abundant. Pharmaceutical and biotechnology companies are increasingly entering the POC space, leveraging their expertise in biopharmaceuticals and vaccines to design innovative devices. Partnerships between technology providers and healthcare institutions are also opening doors for next-generation solutions that integrate seamlessly with electronic health records and telemedicine platforms.

However, the market faces hurdles. While accuracy has improved, some POC devices remain less reliable than centralized laboratory tests, potentially leading to misdiagnoses. High device costs and limited funding in lower-income regions also present barriers. Addressing affordability and accuracy will be critical for sustained growth.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/point-of-care-diagnostics-market

Competitive Landscape

The Point-of-Care Diagnostics Market is highly competitive, with both established leaders and emerging innovators contributing to advancements.

Prominent players such as F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers, Becton Dickinson & Company, Cepheid (Danaher), and Thermo Fisher Scientific continue to expand their portfolios through R&D, acquisitions, and collaborations. At the same time, newer entrants such as Visby Medical, UNIMA Inc., and Jiangsu Mole Bioscience Co. Ltd. are developing portable and affordable solutions to reach underserved populations.

Collaboration remains a central growth strategy. In March 2025, Roche Diagnostics, in partnership with Eli Lilly, introduced the Elecsys Amyloid Plasma Panel, an innovative blood test designed to aid early Alzheimer's detection. Later that year, Roche and Pfizer joined forces to guide COVID-19 positive patients with accessible testing and treatment options. These alliances showcase how cross-industry synergies can accelerate diagnostic innovation.

Shaping the Future of Diagnostics

Looking ahead, the Point-of-Care Diagnostics Market is set to play a central role in the future of healthcare. The focus will be on creating devices that are accurate, cost-effective, and digitally integrated.

As the global population ages and chronic diseases rise, demand for near-patient testing will intensify. Rapid innovations in biosensors, AI-driven analytics, and connected health systems will ensure that POC diagnostics evolve beyond standalone devices to become key components of holistic healthcare ecosystems.

For manufacturers-both established giants and ambitious newcomers-the decade ahead presents a golden opportunity. Expanding product lines, ensuring compliance with evolving regulations, and prioritizing affordability for diverse markets will be vital steps in capturing growth.

Related Reports:

Human Growth Hormone Treatment and Drugs Market: https://www.futuremarketinsights.com/reports/human-growth-hormone-treatment-and-drugs-market

Mortuary Bag Market: https://www.futuremarketinsights.com/reports/mortuary-bag-market

Veterinary Disinfectant for Pets and Farms Market: https://www.futuremarketinsights.com/reports/veterinary-disinfectant-for-pets-and-farms-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.